Diabetes, insulin and new therapeutic strategies for Parkinson’s disease: Focus on glucagon-like peptide-1 receptor agonists
Carmen M. Labandeira, Arturo Fraga-Bau, David Arias Ron, Ana Muñoz, Gema Alonso-Losada, Antonio Koukoulis, J Romero-López, Ana I. Rodríguez‐Pérez
Topics & Concepts
NeurodegenerationDiabetes mellitusNeuroinflammationMedicineParkinson's diseaseInsulinDiseaseNeurogenesisOxidative stressInsulin receptorNeuroscienceBioinformaticsInternal medicineEndocrinologyInsulin resistancePsychologyBiologyParkinson's Disease Mechanisms and TreatmentsDiabetes Treatment and ManagementNuclear Receptors and Signaling